drugset / Trial / NCT05566262
Bodewell Products for the Treatment of Atopic Dermatitis
Phase 4
Active not recruiting
15 enrolled
University of Alabama at Birmingham
Procter and Gamble · collab
NaSingle-groupOpen-labelTreatment
Summary
This study aims to examine the safety and efficacy of topical application of the Bodewell eczema products
Timeline
- Start
- 2023-11-01
- Primary completion
- 2027-02
- Completion
- 2028-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bodewell Calming Cream | Unknown | — | Topical |